UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR September 2014


IN THIS ISSUE

~~~~
EVENTS

Oct. 03, 2014
FirstFridays @ OIP
Topic:  "App Development Resources at UCLA"

Sept. 18, 2014
CODE FOR THE MISSION
App Competition - Winners Announced at MMWCON 2014

More Events

       
Forbes

Forbes Magazine Ranks UCLA #5 on America's Most Entrepreneurial Universities List
Forbes Magazine's 2014 list of America's Most Entrepreneurial Universities places six California universities in the top ten. Forbes ranked the nation's universities based on a ratio of alumni data from LinkedIn and the school's total student body.
ImaginAb

ImaginAb Enters into Licensing Agreement with UCLA
Under the agreement, ImaginAb gains exclusive access to novel imaging agents that target specific markers of murine T-cells, enabling a new understanding of response to immunotherapeutic drugs in pre-clinical models.
UCLA Advanced Materials Event

OIP-ISR to Host UCLA Advanced Materials Partnering Conference | Nov. 5, 2014, 9AM-4PM, UCLA
The conference includes panelists from corporate and venture capital firms, as well as domestic and international regulatory bodies. Startups and inventors from academic institutions across the SoCal region will be in attendance.
Vault Nano

UCLA Startup Vault Nano - Bringing Tumor-Fighting Vaults to Clinical Trials
In collaboration with UCLA's Steven Dubinett and Jay Lee, Vault Nano is moving the CCL21-vault into clinical studies, hoping to initiate a Phase 1 trial by the end of next year.
Intellectual Property

Intellectual Property - Valuable to Every Discipline
Intellectual property — patents, copyright, trademarks, trade secrets — plays a vital role in economic growth and prosperity. Yet outside of law schools, most American colleges provide little or no opportunity for students to receive any substantive instruction in it.

Intellectual Property Announcements


New U.S. Patents Awarded
  • 8,809,546 - Preparation of functionalized zeolitic frameworks  | O. Yaghi, et al.
  • 8,805,703 - Generation and dissemination of automatically pre-populated clinical notes  | N. Martin, et al.
  • 8,805,542 - Parylene-based microelectrode array implant for spinal cord stimulation  | R. Edgerton, et al.
  • 8,802,835 - Proteins with repetitive bacterial-Ig-like (Big) domains present in. . . | D. Haake, et al.
  • 8,802,689 - Androgen receptor modulator for the treatment of prostate cancer and. . . | M. Jung, et al.
  • 8,796,233 - Methods and systems for modulating hormones and related methods. . . | S. Pandol, et al.
  • 8,791,092 - Molecular tweezers for the treatment of amyloid-related diseases  | S. Frautschy, et al.

~~~~

New UCLA Technologies Available for Licensing


SEARCH MORE TECHNOLOGIES

~~~~
    UCLA Invents - Previous Issue
    • University of California Reverses Investment Policy on Startups
    • UCLA Startup ArmaGen Enters $225M Licensing Deal with Shire
    • Kythera Announces FDA Acceptance of ATX-101 NDA
    • Venturing into a New Model - UCLA VC Fund
    • New UCLA Technologies Available for Licensing
    • UCLA Patents Awarded
    • Read Previous Issue | View Newsletter Archive
    UCLA TechMatch Program

    Customized, automated service matches UCLA innovation with
    industry research and technology licensing interests.  Subscribe today.

    UCLA Invents Newsletter, Vol. 3, No. 1

    How to Subscribe: 
    http://oip.ucla.edu/UCLAinvents

    View Newsletter Archive

    Send editorial comments and corrections to:  
    Bob Nidever, Editor,  bnidever@research.ucla.edu

    Contributors: Neil Bajpayee, Howard Chang, Miles Gerson

    UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
    11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

    Copyright © 2014 The Regents of the University of California. All Rights Reserved.